Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Insys Therapeutics, Inc. (INSY) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2020 8-K Quarterly results
02/10/2020 8-K Quarterly results
02/05/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Second Amendment to Transition Services Agreement, by and between Benuvia Therapeutics Inc. and Insys Therapeutics, Inc"
01/17/2020 8-K Regulation FD Disclosure
01/10/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Second Plan Supplement Pursuant to the Second Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors, filed with the United States Bankruptcy Court for the District of Delaware"
12/26/2019 8-K Quarterly results
12/03/2019 8-K Entry into a Material Definitive Agreement, Changes in Registrant's Certifying Accountant, Regulation FD Disclosure, Financia...
Docs: "Asset Purchase Agreement, by and between Renaissance Lakewood, LLC and Insys Therapeutics, Inc",
"Letter from BDO USA, LLP",
"Second Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors",
"Disclosure Statement for Second Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors"
11/20/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors",
"Disclosure Statement for Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors"
11/04/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Transition Services Agreement, by and between Chilion Group Holdings US, Inc. and Insys Therapeutics, Inc",
"Monthly Operating Report, for the period covering September 1, 2019 through September 30, 2019, filed with the United States Bankruptcy Court for the District of Delaware"
10/25/2019 8-K Quarterly results
10/02/2019 8-K Quarterly results
09/27/2019 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
09/26/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "ASSET PURCHASE AGREEMENT BETWEEN PHARMBIO KOREA, INC. AND INSYS THERAPEUTICS, INC. DATED AS OF SEPTEMBER 25, 2019"
09/17/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors",
"Disclosure Statement for Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors"
09/09/2019 8-K Quarterly results
09/03/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "ASSET PURCHASE AGREEMENT BETWEEN BTcP PHARMA, LLC, AND INSYS THERAPEUTICS, INC. DATED AS OF September 1, 2019"
08/29/2019 8-K Other Events
08/13/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report, for the period covering June 10, 2019 through June 30, 2019, filed with the United States Bankruptcy Court for the District of Delaware"
08/08/2019 8-K Quarterly results
07/19/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Initial Monthly Operating Report filed with the United States Bankruptcy Court for the District of Delaware"
07/15/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/10/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
06/10/2019 8-K Bankruptcy or Receivership, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities Company to Facilitate Transaction Process and Sale of Substantially All Assets Through Chapter 11 of the U.S. Bankruptcy Code"
06/07/2019 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/05/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/24/2019 8-K Quarterly results
04/23/2019 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/23/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/18/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "INSYS Therapeutics Implements Leadership Changes Andrew G. Long Appointed Chief Executive Officer"
03/07/2019 8-K Quarterly results
11/05/2018 8-K Quarterly results
Docs: "INSYS Therapeutics Reports Third Quarter 2018 Results Company’s Position as a Leader and Strategic Partner in Pharmaceutical Cannabinoids Strengthens with Involvement in Seven CBD Clinical Trials"
10/10/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement for Mark E. Nance, Chief Legal Officer and General Counsel",
"INSYS Therapeutics Names New General Counsel"
08/08/2018 8-K Quarterly results
Docs: "INSYS Therapeutics Reports Second Quarter 2018 Results Focus remains on advancing pipeline across cannabinoid and spray platforms"
04/02/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy